SCHEMBL29676754

SCHEMBL29676754

Cc1ccc(Cl)c(-c2ccncc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.42
MAPK13 O15264 5/20 0.42
MAPK12 P53778 5/20 0.42
MAPK11 Q15759 5/20 0.42
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
GCGR P47871 2/20 0.38
RAB9A P51151 4/20 0.37
NPC1 O15118 3/20 0.37
RAF1 P04049 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
BRAF P15056 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26606982 0.82 ADORA1 (0.49) MAPTLMNARAB9AALDH1A1KDM4E
SCHEMBL30573063 0.82 ADORA1 (0.49) MAPTLMNARAB9AALDH1A1KDM4E
SCHEMBL21022103 0.78 ADORA2A (0.43) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL18652678 0.76 MAPK14 (0.46) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL1345243 0.71 MAPK14 (0.38) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL16385603 0.69 ESR2 (0.47) MAPTALDH1A1KDM4E
SCHEMBL2458840 0.69 ADORA1 (0.49) ALDH1A1KDM4EADORA2AADORA2B
SCHEMBL13829027 0.69 MAPK14 (0.40) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL16385601 0.67 MAPT (0.44) MAPTLMNARAB9ANPC1KDM4E
SCHEMBL31665902 0.67 MAPT (0.62) MAPK14MAPK13MAPK12MAPK11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109096274-B Biaryl compounds useful in the treatment of human oncological, neurological and immunological diseases 比奥根MA公司 2022-07-01 CN disclosed